The next big beneficiary is， of course， OpenAI for two reasons.

1） IPO： OpenAI is concerned that Anthropic would preempt its IPO， resulting in a better valuation. And this was recently a likely scenario. This would have created the image of a second-rate competitor. Now， the question is， how will the ban affect Anthropic's valuation and its upcoming IPO？ Who wants to invest in a company that has become persona non grata with US authorities （due to supply chain risk） and may not even be allowed to distribute its best models to enterprises， let alone globally？ This will certainly put a significant downward pressure on the valuation.

2） OpenAI has the opportunity to learn from this， to proactively engage in discussions with US authorities to avoid such a disaster in advance， to determine how its model needs to be structured， to obtain the authorities' approval beforehand， and thus essentially use the time to develop a model and secure the necessary authorization to distribute it. OpenAI can learn from this situation and presumably has a better relationship with the US government than Anthropic.